Comparison of neurodegeneration and cognitive impairment in neonatal mice exposed to propofol or isoflurane.

BACKGROUND:While previous studies have demonstrated neuronal apoptosis and associated cognitive impairment after isoflurane or propofol exposure in neonatal rodents, the effects of these two anesthetics have not been directly compared. Here, we compare and contrast the effectiveness of isoflurane an...

Full description

Bibliographic Details
Main Authors: Bin Yang, Ge Liang, Soorena Khojasteh, Zhen Wu, Wenqiong Yang, Donald Joseph, Huafeng Wei
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4059617?pdf=render
id doaj-820519cf54064870b503040877d9c017
record_format Article
spelling doaj-820519cf54064870b503040877d9c0172020-11-24T21:52:02ZengPublic Library of Science (PLoS)PLoS ONE1932-62032014-01-0196e9917110.1371/journal.pone.0099171Comparison of neurodegeneration and cognitive impairment in neonatal mice exposed to propofol or isoflurane.Bin YangGe LiangSoorena KhojastehZhen WuWenqiong YangDonald JosephHuafeng WeiBACKGROUND:While previous studies have demonstrated neuronal apoptosis and associated cognitive impairment after isoflurane or propofol exposure in neonatal rodents, the effects of these two anesthetics have not been directly compared. Here, we compare and contrast the effectiveness of isoflurane and propofol to cause neurodegeneration in the developing brain and associated cognitive dysfunction. METHODS:Seven-day-old mice were used. Mice in the isoflurane treatment group received 6 h of 1.5% isoflurane, while mice in propofol treatment group received one peritoneal injection (150 mg/kg), which produced persistent anesthesia with loss of righting for at least 6 h. Mice in control groups received carrying gas or a peritoneal injection of vehicle (intralipid). At 6 h after anesthetic treatment, a subset of each group was sacrificed and examined for evidence of neurodegeneration, using plasma levels of S100β, and apoptosis using caspase-3 immunohistochemistry in the cerebral cortex and hippocampus and Western blot assays of the cortex. In addition, biomarkers for inflammation (interleukin-1, interleukin-6, and tumor necrosis factor alpha) were examined with Western blot analyses of the cortex. In another subset of mice, learning and memory were assessed 32 days after the anesthetic exposures using the Morris water maze. RESULTS:Isoflurane significantly increased plasma S100β levels compared to controls and propofol. Both isoflurane and propofol significantly increased caspase-3 levels in the cortex and hippocampus, though isoflurane was significantly more potent than propofol. However, there were no significant differences in the inflammatory biomarkers in the cortex or in subsequent learning and memory between the experimental groups. CONCLUSION:Both isoflurane and propofol caused significant apoptosis in the mouse developing brain, with isoflurane being more potent. Isoflurane significantly increased levels of the plasma neurodegenerative biomarker, S100β. However, these neurodegenerative effects of isoflurane and propofol in the developing brain were not associated with effects on inflammation or with cognitive dysfunction in later life.http://europepmc.org/articles/PMC4059617?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Bin Yang
Ge Liang
Soorena Khojasteh
Zhen Wu
Wenqiong Yang
Donald Joseph
Huafeng Wei
spellingShingle Bin Yang
Ge Liang
Soorena Khojasteh
Zhen Wu
Wenqiong Yang
Donald Joseph
Huafeng Wei
Comparison of neurodegeneration and cognitive impairment in neonatal mice exposed to propofol or isoflurane.
PLoS ONE
author_facet Bin Yang
Ge Liang
Soorena Khojasteh
Zhen Wu
Wenqiong Yang
Donald Joseph
Huafeng Wei
author_sort Bin Yang
title Comparison of neurodegeneration and cognitive impairment in neonatal mice exposed to propofol or isoflurane.
title_short Comparison of neurodegeneration and cognitive impairment in neonatal mice exposed to propofol or isoflurane.
title_full Comparison of neurodegeneration and cognitive impairment in neonatal mice exposed to propofol or isoflurane.
title_fullStr Comparison of neurodegeneration and cognitive impairment in neonatal mice exposed to propofol or isoflurane.
title_full_unstemmed Comparison of neurodegeneration and cognitive impairment in neonatal mice exposed to propofol or isoflurane.
title_sort comparison of neurodegeneration and cognitive impairment in neonatal mice exposed to propofol or isoflurane.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2014-01-01
description BACKGROUND:While previous studies have demonstrated neuronal apoptosis and associated cognitive impairment after isoflurane or propofol exposure in neonatal rodents, the effects of these two anesthetics have not been directly compared. Here, we compare and contrast the effectiveness of isoflurane and propofol to cause neurodegeneration in the developing brain and associated cognitive dysfunction. METHODS:Seven-day-old mice were used. Mice in the isoflurane treatment group received 6 h of 1.5% isoflurane, while mice in propofol treatment group received one peritoneal injection (150 mg/kg), which produced persistent anesthesia with loss of righting for at least 6 h. Mice in control groups received carrying gas or a peritoneal injection of vehicle (intralipid). At 6 h after anesthetic treatment, a subset of each group was sacrificed and examined for evidence of neurodegeneration, using plasma levels of S100β, and apoptosis using caspase-3 immunohistochemistry in the cerebral cortex and hippocampus and Western blot assays of the cortex. In addition, biomarkers for inflammation (interleukin-1, interleukin-6, and tumor necrosis factor alpha) were examined with Western blot analyses of the cortex. In another subset of mice, learning and memory were assessed 32 days after the anesthetic exposures using the Morris water maze. RESULTS:Isoflurane significantly increased plasma S100β levels compared to controls and propofol. Both isoflurane and propofol significantly increased caspase-3 levels in the cortex and hippocampus, though isoflurane was significantly more potent than propofol. However, there were no significant differences in the inflammatory biomarkers in the cortex or in subsequent learning and memory between the experimental groups. CONCLUSION:Both isoflurane and propofol caused significant apoptosis in the mouse developing brain, with isoflurane being more potent. Isoflurane significantly increased levels of the plasma neurodegenerative biomarker, S100β. However, these neurodegenerative effects of isoflurane and propofol in the developing brain were not associated with effects on inflammation or with cognitive dysfunction in later life.
url http://europepmc.org/articles/PMC4059617?pdf=render
work_keys_str_mv AT binyang comparisonofneurodegenerationandcognitiveimpairmentinneonatalmiceexposedtopropofolorisoflurane
AT geliang comparisonofneurodegenerationandcognitiveimpairmentinneonatalmiceexposedtopropofolorisoflurane
AT soorenakhojasteh comparisonofneurodegenerationandcognitiveimpairmentinneonatalmiceexposedtopropofolorisoflurane
AT zhenwu comparisonofneurodegenerationandcognitiveimpairmentinneonatalmiceexposedtopropofolorisoflurane
AT wenqiongyang comparisonofneurodegenerationandcognitiveimpairmentinneonatalmiceexposedtopropofolorisoflurane
AT donaldjoseph comparisonofneurodegenerationandcognitiveimpairmentinneonatalmiceexposedtopropofolorisoflurane
AT huafengwei comparisonofneurodegenerationandcognitiveimpairmentinneonatalmiceexposedtopropofolorisoflurane
_version_ 1725877245159931904